Wenhui Lou

1.7k total citations
62 papers, 1.1k citations indexed

About

Wenhui Lou is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Wenhui Lou has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 27 papers in Surgery and 18 papers in Cancer Research. Recurrent topics in Wenhui Lou's work include Pancreatic and Hepatic Oncology Research (43 papers), Pancreatitis Pathology and Treatment (16 papers) and Cancer Genomics and Diagnostics (10 papers). Wenhui Lou is often cited by papers focused on Pancreatic and Hepatic Oncology Research (43 papers), Pancreatitis Pathology and Treatment (16 papers) and Cancer Genomics and Diagnostics (10 papers). Wenhui Lou collaborates with scholars based in China, United States and Taiwan. Wenhui Lou's co-authors include Wenchuan Wu, Ning Pu, Dansong Wang, Tiantao Kuang, Hanlin Yin, Qiangda Chen, Dayong Jin, Xu Han, Guochao Zhao and Yefei Rong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Annals of Surgery.

In The Last Decade

Wenhui Lou

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenhui Lou China 19 582 418 388 233 180 62 1.1k
Masaaki Miyo Japan 17 421 0.7× 482 1.2× 275 0.7× 160 0.7× 119 0.7× 56 967
Dingkong Liang China 18 573 1.0× 634 1.5× 439 1.1× 140 0.6× 145 0.8× 21 1.1k
Naotake Funamizu Japan 15 516 0.9× 374 0.9× 294 0.8× 255 1.1× 209 1.2× 82 1.1k
Massimo Pancione Italy 21 427 0.7× 659 1.6× 370 1.0× 88 0.4× 135 0.8× 48 1.2k
Lin Guo China 21 332 0.6× 731 1.7× 440 1.1× 96 0.4× 180 1.0× 71 1.3k
Arihiro Aihara Japan 19 408 0.7× 513 1.2× 327 0.8× 180 0.8× 87 0.5× 45 999
Guido Giordano Italy 16 493 0.8× 267 0.6× 225 0.6× 104 0.4× 179 1.0× 76 916
Yu Lou China 15 416 0.7× 525 1.3× 403 1.0× 110 0.5× 150 0.8× 28 1.1k
Chengrong Xie China 20 772 1.3× 655 1.6× 684 1.8× 395 1.7× 179 1.0× 44 1.5k

Countries citing papers authored by Wenhui Lou

Since Specialization
Citations

This map shows the geographic impact of Wenhui Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhui Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhui Lou more than expected).

Fields of papers citing papers by Wenhui Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenhui Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhui Lou. The network helps show where Wenhui Lou may publish in the future.

Co-authorship network of co-authors of Wenhui Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Wenhui Lou. A scholar is included among the top collaborators of Wenhui Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenhui Lou. Wenhui Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zheng, Huaxiang Xu, Junyi He, et al.. (2025). Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells. Cell Death and Disease. 16(1). 28–28. 6 indexed citations
2.
Feng, Jiale, Xu Han, Ying Ying, et al.. (2024). The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy. Cancers. 16(2). 289–289. 9 indexed citations
3.
Chen, Qiangda, Hanlin Yin, Siyao Liu, et al.. (2024). Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer. Journal for ImmunoTherapy of Cancer. 12(3). e008694–e008694. 8 indexed citations
5.
Chen, Qiangda, Hanlin Yin, Junyi He, et al.. (2023). Tumor Microenvironment Responsive CD8+ T Cells and Myeloid‐Derived Suppressor Cells to Trigger CD73 Inhibitor AB680‐Based Synergistic Therapy for Pancreatic Cancer. Advanced Science. 10(33). e2302498–e2302498. 17 indexed citations
6.
Song, Jianning, Yingchi Yang, Yingchi Yang, et al.. (2021). Association of Abdominal Incision Length With Gastrointestinal Function Recovery Post-operatively: A Multicenter Registry System-Based Retrospective Cohort Study. Frontiers in Surgery. 8. 743069–743069. 6 indexed citations
7.
Yin, Hanlin, Ning Pu, Qiangda Chen, et al.. (2021). Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer. Cell Death and Disease. 12(11). 1033–1033. 60 indexed citations
8.
Han, Xu, Yuan Fang, Pingping Chen, et al.. (2021). Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis. Cell Cycle. 20(4). 369–382. 30 indexed citations
9.
Pu, Ning, Qiangda Chen, Wei Gan, et al.. (2021). Lymph Node Metastatic Patterns and Survival Predictors Based on Tumor Size in Pancreatic Ductal Adenocarcinoma. Advances in Therapy. 38(8). 4258–4270. 11 indexed citations
10.
Pu, Ning, et al.. (2021). Current status and future perspectives of clinical research in pancreatic cancer: Establishment of evidence by science. Journal of Hepato-Biliary-Pancreatic Sciences. 29(7). 741–757. 7 indexed citations
11.
Chen, Qiangda, et al.. (2021). Chemokine C‐C motif ligand 21 synergized with programmed death‐ligand 1 blockade restrains tumor growth. Cancer Science. 112(11). 4457–4469. 10 indexed citations
12.
Ma, Lixiang, Xu Han, Ji Li, et al.. (2020). The physiological characteristics of the basal microvilli microvessels in pancreatic cancers. Cancer Medicine. 9(15). 5535–5545. 3 indexed citations
13.
Kuang, Tiantao, Ning Pu, Yuan Fang, et al.. (2019). TRAF6 regulates YAP signaling by promoting the ubiquitination and degradation of MST1 in pancreatic cancer. Clinical and Experimental Medicine. 19(2). 211–218. 25 indexed citations
14.
Pu, Ning, Lingdi Yin, Joseph R. Habib, et al.. (2019). Optimized Modification of the Eighth Edition of AJCC TNM Staging System for Resected Pancreatic Ductal Adenocarcinoma. Future Oncology. 15(30). 3457–3465. 10 indexed citations
15.
Ma, Tao, Xueli Bai, Wen Chen, et al.. (2019). Surgical management and outcome of grade-C pancreatic fistulas after pancreaticoduodenectomy: A retrospective multicenter cohort study. International Journal of Surgery. 68. 27–34. 12 indexed citations
16.
Pu, Ning, Yaolin Xu, Yuan Fang, et al.. (2018). Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis. Cancer Management and Research. Volume 10. 227–238. 37 indexed citations
17.
Fang, Yuan, Xu Han, Lingxiao Liu, & Wenhui Lou. (2018). Diagnosis and treatment efficacy of digital subtraction angiography and transcatheter arterial embolization in post-pancreatectomy hemorrhage: A single center retrospective cohort study. International Journal of Surgery. 51. 223–228. 11 indexed citations
18.
Xu, Xuefeng, Yang Lv, Lei Zhang, et al.. (2018). Application of a novel embeddedness‑like pancreaticojejunostomy anastomosis technique used in pancreaticoduodenectomy. Oncology Letters. 15(5). 8067–8071. 1 indexed citations
19.
Yuan, Peng, Jing Cao, Yong Li, et al.. (2016). KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis. Cancer Research. 77(1). 100–111. 86 indexed citations
20.
Lou, Wenhui. (2009). Diagnosis and clinical staging of pancreatic cancer. Zhongguo aizheng zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026